gabexate has been researched along with Atresia, Biliary in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, Y | 1 |
| Hoshino, K | 1 |
| Morikawa, Y | 1 |
| Okamura, J | 1 |
| Hotta, R | 1 |
| Komori, K | 1 |
| Nakao, S | 1 |
| Obara, H | 1 |
| Kawachi, S | 1 |
| Fuchimoto, Y | 1 |
| Tanabe, M | 1 |
| Shimazu, M | 1 |
| Kitajima, M | 1 |
1 other study available for gabexate and Atresia, Biliary
| Article | Year |
|---|---|
Successful liver transplantation across the ABO incompatibility barrier in 6 cases of biliary atresia.
Topics: ABO Blood-Group System; Adolescent; Adult; Alprostadil; Biliary Atresia; Child; Clinical Protocols; | 2006 |